Janux Therapeutics Inc (JANX)
47.98
+0.07
(+0.15%)
USD |
NASDAQ |
May 15, 14:13
Janux Therapeutics Total Return Price: 47.98 for May 15, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 14, 2024 | 47.91 |
| May 13, 2024 | 49.99 |
| May 10, 2024 | 48.92 |
| May 09, 2024 | 51.94 |
| May 08, 2024 | 55.37 |
| May 07, 2024 | 61.50 |
| May 06, 2024 | 62.19 |
| May 03, 2024 | 64.78 |
| May 02, 2024 | 62.43 |
| May 01, 2024 | 58.19 |
| April 30, 2024 | 57.00 |
| April 29, 2024 | 56.08 |
| April 26, 2024 | 47.39 |
| April 25, 2024 | 47.10 |
| April 24, 2024 | 48.21 |
| April 23, 2024 | 49.78 |
| April 22, 2024 | 48.88 |
| April 19, 2024 | 48.69 |
| April 18, 2024 | 48.85 |
| April 17, 2024 | 47.96 |
| April 16, 2024 | 50.55 |
| April 15, 2024 | 51.86 |
| April 12, 2024 | 52.65 |
| April 11, 2024 | 50.00 |
| April 10, 2024 | 44.62 |
| Date | Value |
|---|---|
| April 09, 2024 | 40.03 |
| April 08, 2024 | 38.63 |
| April 05, 2024 | 35.12 |
| April 04, 2024 | 35.40 |
| April 03, 2024 | 36.34 |
| April 02, 2024 | 35.87 |
| April 01, 2024 | 37.69 |
| March 28, 2024 | 37.65 |
| March 27, 2024 | 37.92 |
| March 26, 2024 | 38.84 |
| March 25, 2024 | 38.53 |
| March 22, 2024 | 39.53 |
| March 21, 2024 | 39.85 |
| March 20, 2024 | 39.13 |
| March 19, 2024 | 38.63 |
| March 18, 2024 | 38.81 |
| March 15, 2024 | 39.45 |
| March 14, 2024 | 37.77 |
| March 13, 2024 | 39.92 |
| March 12, 2024 | 38.83 |
| March 11, 2024 | 39.97 |
| March 08, 2024 | 39.81 |
| March 07, 2024 | 40.61 |
| March 06, 2024 | 42.07 |
| March 05, 2024 | 43.24 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
5.85
Minimum
Nov 09 2023
64.78
Maximum
May 03 2024
17.78
Average
14.20
Median
Jun 07 2023
Total Return Price Benchmarks
| Viking Therapeutics Inc | 76.98 |
| Equillium Inc | 1.55 |
| Minerva Neurosciences Inc | 2.53 |
| Arvinas Inc | 33.11 |
| Calidi Biotherapeutics Inc | 0.237 |